Zepbound 2.5 mg: The Starting Dose Nobody Is Supposed to Stay On

2.5 mg is a starting dose, and the label is unusually direct about it: it is "not a maintenance dose."¹ You take it once weekly for four weeks so your gut can adapt, then step up. Every efficacy figure you have read about Zepbound — the ~21% mean weight loss over 72 weeks — comes from people who titrated well past this dose².

That is the whole answer, and it is worth stating up front because the two most common questions about 2.5 mg both come from assuming otherwise: why am I not losing much? and can I just stay here since it is cheapest?

What the dose is actually for

Tirzepatide's side effects are overwhelmingly gastrointestinal and overwhelmingly worst when the dose changes. Nausea, constipation, diarrhea and vomiting cluster around escalation and settle as the body adapts¹. Starting everyone at a full therapeutic dose would make the drug intolerable for a large share of people who do fine on it after a gradual ramp.

So the first four weeks are a tolerance exercise, not a treatment attempt. The label's schedule: 2.5 mg once weekly for 4 weeks, then increase to 5 mg, with further increases in 2.5 mg steps no sooner than every 4 weeks, to a maximum of 15 mg¹. The full ladder and the timing is in the tirzepatide dosage chart.

What to expect in month one

Some weight loss, and less than you are hoping for. Appetite suppression usually begins within the first week or two, and early loss is real but modest — this month is largely about establishing tolerance. If you are measuring success against the trial headline, you are measuring against a dose you have not reached.

Side effects, most likely mild and front-loaded. Nausea and constipation are the two most people meet first. Practical management is in tirzepatide and nausea and tirzepatide constipation, and the eating patterns that reduce both are in what to eat on tirzepatide.

A dose you may not tolerate, which is information. If 2.5 mg is genuinely rough, that is worth telling the prescriber before escalating rather than after.

What it costs

2.5 mg is the cheapest rung on every brand route, which is exactly why people ask about staying on it.

• •LillyDirect self-pay: $299 a month for a 28-day supply, as vials or as the four-dose KwikPen — the lowest brand price available to a cash payer³⁴.
• •Commercial insurance that covers Zepbound: as little as $25 with the savings card.
• •Medicare Part D: $50 through the GLP-1 Bridge, KwikPen only — see the KwikPen page.

One thing to plan for: the price goes up as you titrate. 5 mg is $399 and everything from 7.5 mg is $449, and the higher tiers carry the roughly 45-day refill condition³. Budgeting from the 2.5 mg price sets up a surprise in month two. The full route map is in Zepbound cost and savings.

"Can I just stay on 2.5 mg?"

This comes up constantly, usually for cost, sometimes because someone is doing well and does not want to disturb it. The honest answer has two halves.

As a general plan, no — and the label is explicit. 2.5 mg is not a maintenance dose¹. The evidence for what tirzepatide does was generated at 5, 10 and 15 mg². Staying at the starting dose to save money means paying $299 a month for a dose the trials did not test as treatment.

As an individual clinical decision, sometimes yes. Some people get meaningful appetite suppression at low doses, and some cannot tolerate escalation at all. A prescriber may reasonably hold someone at a lower dose — that is a judgment about a specific patient, made by someone who can see them, and it is different from choosing the cheapest rung as a strategy.

What it is not is the same thing as "microdosing." A number of telehealth programs market low-dose or microdose tirzepatide tiers at attractive prices; those are compounded products at doses below the studied ladder, and the price gap does persuasive work the evidence does not support. If you are weighing one, read the compounded programs we track with the dose beside each price.

The unit conversion, if you have a compounded vial

If your 2.5 mg comes from a compounded program rather than a Lilly pen, do not carry a units number in your head. The volume that equals 2.5 mg depends entirely on your vial's concentration, and across the concentrations in circulation the same 2.5 mg dose ranges from roughly 6 to 50 units on a U-100 syringe. Check the concentration on your vial every time: how many units is 2.5 mg of tirzepatide.

The bottom line

2.5 mg is a four-week tolerance step, and Zepbound's label states plainly that it is not a maintenance dose¹. Expect modest early loss and front-loaded gut side effects, then a step to 5 mg. It is the cheapest brand rung — $299 self-pay, $25 with commercial coverage, $50 on the Medicare Bridge — and the price rises to $399 and then $449 as you titrate, so budget for the ladder rather than the first rung³. Staying at 2.5 mg to save money means paying for a dose that was never tested as treatment; staying there because a prescriber decided you should is a different thing entirely.